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Introduction. The choice of antimicrobial treatment for septice-
mia is often empirical and based on the knowledge of local anti-
microbial activity patterns of the most common bacteria causing 
such bloodstream infections. The current study aimed to study the 
prevalence of bacterial pathogens causing septicemia and their 
antimicrobial resistant profiles in hospital admitted patients.
Methods. This cross sectional study done at Children’s Medical 
Center, Tehran, Iran. We examined 168 bacterial strains iso-
lated from 186 clinically diagnosed septicemia cases refereed at 
Children’s Medical Center, Tehran, Iran Over a period of twelve 
months from July 2010 to 2011 July. 11446 blood samples from 
patients of clinically suggestive septicemia were evaluated.
Results. Bacterial strains were isolated from 910 (7.95%) of blood 
cultures. Gram-negative bacteria identified were  Pseudomonas 
species (20.5%), Pseudomonas aeruginosa (1.86%), Salmonella 
spp (1.09%), Acinetobacter naumannii (8.13%), Escherichia coli 
(4.06%), Klebsiella spp (5.16%). Gram-negative pathogens were 
more than gram positive in bloodstream infections. Antimicrobial 
susceptibility testing was done according to Clinical and Labo-
ratory Standards Institute (CLSI, USA) guidelines against: ami-
kacin ampicillin, amoxicillin, amoxiclav, cefuroxime, cefotaxime, 
ceftazidime, cefoperazone tetracycline, chloramphenicol, cipro-
floxacin, gentamicin. Resistanc to different antibiotics in the most 
important isolated bacteria were: 32.1 %, 10.8%, 87.8%, 96%, 
39.1%, 35.2, 49.4%, 69%, 80.02%, 22%, 59%, 30.1% respec-
tively, for Pseudomonas spp, 32%, 3.7%, 84.2 %, 83.2%, 80.1%, 
75.4%, 44.8%, 45.2%, 33.3%, 19%, 34.1, 11.5% respectively for 
Acinetobacter species. 
Discussion. Resistant to majority of the antimicrobial agents for 
several pathogens implicated in bloodstream infections, particu-
larly in Gram-negative bacteria, can make complication in treat-
ment of infection cause by them.
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Summary
Introduction
The increasing bloodstream infections mainly in develop-
ing countries is the one of most important health care sys-
tems concerne. Although the bloodstream infections mor-
tality rate has reduced in latest two decades. Many studies 
worldwide have determined rising antibiotics resistance 
among causative bacteria for septicemia [1-3]. It can can 
lead to make a major challenge for the physicians for 
treatment of tham, because of they face to increase of 
antibiotics resistance in causative bacteria for septice-
mia [3-5].
Both Gram-negative and Gram-positive bacteria can 
cause bloodstream infections and that can be differs 
from different locality and/or different time [1, 2, 8]. 
Rapid and accurate diagnosis and select the appropri-
ate antimicrobial treatment for patients with septicemia 
can help to decrease mortality and morbidity  [7, 9]. 
Actually, for selection of empirical antibiotic therapy 
for bloodstream infections consider local antibiotic re-
sistance paterns in frequent pathogens associated with 
septicemia is necessary and can be one of important 
point. 
So, this study was performed to find the frequency of 
Gram-negative bacteria that causing septicemia in Chil-
dren’s Medical Center hospital admitted patients and de-
termined antimicrobial resistance profile till clinicians 
can select the best choice antibiotic therapy.
Methods
This study was performed at a Children’s Medical Cent-
er, Tehran, Iran, over a period of twelve months from 
July 2010 to 2011 July. During the current study, 803 
blood samples from patients of clinically suggestive 
bloodstream infection were surveyed, out of 4162 pa-
tients admitted. An informed consent was achieved from 
the patients. Blood samples from neonates and pediat-
rics were collected by pediatricians. Blood samples were 
gathered after careful cleaning of the venous with 70% 
alcohol and consequently followed by povidone iodine. 
Under the aseptic conditions 5 ml of blood was drawn 
by venipuncture and transmitted into two culture bot-
tles each containing 50 ml of 0.5% bile-broth and 50 ml 
of 0.5% glucose-broth. Both the bottles were incubated 
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at 37°C for 10 days aerobically. Routine subculturing 
was performed on MacConkey agar and 5% sheep blood 
agar after 24 hours, 48 hours, 5th day and 10th day. In 
between these time points, subculturing was performed 
until there was observable turbidity. Microorganisms 
that isolated from blood culture were recognized by 
cultural characters, morphology and variety of standard 
biochemical tests such as oxidase,TSI, SIM, citrate, OF, 
Lysine decarboxilase, gelatinase, MR/VP, etc. [10-15]
 Antimicrobial resistant patterns of the bacterial isolates 
to several antimicrobials was detected by using the Kirby 
Bauer disc diffusion method by Clinical and Laboratory 
Standards Institute (CLSI) guidelines [11]. The antibiotic 
concentration for each disc was as follows: gentamicin 
(10μg), amikacin (30μg), ampicillin (10μg), amoxicillin 
(30μg), amoxiclav (20:10μg), cefoxitin (30μg), cefotaxi-
me (30μg), cefuroxime (30μg), ceftazidime (30μg), cefop-
erazone (75μg), ciprofloxacin (5μg), tetracycline (30μg) 
and chloramphenicol (30μg) for all organisms. All the an-
tibiotic discs were purchased from MAST company (UK).
Results
Demographics
Over a period of twelve months from July 2010 to 2011 
July. 11446 blood samples from patients of clinically 
suggestive septicemia were evaluated. The causative 
organism could be identified in 910 (7.95%) bacterial 
strains. Gram-negative bacteria identified were  Pseu-
domonas species 187 (20.5%), Acinetobacter baumannii 
74 (8.13%), Klebsiella spp 47 (5.16%), Escherichia coli 
37 (4.06%), Salmonella spp 10 (1.09%), Pseudomonas 
aeruginosa 17 (1.86%) (Tab. I).
The rates of resistance in Pseudomonas spp to various 
antimicrobials are given below: gentamicin (30.1%), 
amikacin (10.8%), ampicillin (87.8%), amoxicillin 
(96%), amoxiclav (80.02%), cefuroxime (69%), ce-
fotaxime (49.4%), cefazidime (35.2%), cefoperazone 
(39.1%), ciprofloxacin (22%), chloramphenicol (59%) 
and tetracycline (32.1 %) (Tab. II).
The rates of resistance in  Acinetobacter  species to 
various antimicrobials are given below: gentamicin 
(11.5%), amikacin (3.7%), ampicillin (84.2 %), amoxi-
cillin (83.2%), amoxiclav (80.1%), cefuroxime (75.4%), 
cefotaxime (44.8%), ceftazidime (45.2%), cefopera-
zone (33.3%), ciprofloxacin (19%),, chloramphenicol 
(34.1%) and tetracycline (32%) (table. 2).
The rates of resistance in Salmonella spp to various an-
timicrobials are given below: cefuroxime (21%), cefo-
taxime (39%), ampicillin (46.4%), amoxicillin (27.3%), 
amoxiclav (15.4%), cefoperazone (32.5%),, ciprofloxa-
cin (6.3%), chloramphenicol (9.1%) and tetracycline 
(50%) (Tab. II). 
The rates of resistance in Escherichia coli to various anti-
microbials are given below: gentamicin (25%), amikacin 
(18%), ampicillin (92%), amoxicillin (90.9%), amoxi-
clav (73.9%), cefuroxime (54.5%), cefotaxime (52.9%), 
cefoperazone (36.8%), ciprofloxacin (31.6%), chloram-
phenicol (39%) and tetracycline (33.7%) (Tab. II).
The rates of resistance in Pseudomonas aeruginosa  to 
various antimicrobials are given below: gentamicin 
(42.2%), amikacin (30.8%), ampicillin (96.1%), amoxi-
cillin (92.9%), amoxiclav (95.8%), cefuroxime (81%), 
cefotaxime (48.4%), cefazidime (34.2%), cefoperazone 
(47.3%), ciprofloxacin (22.4%), chloramphenicol (32%) 
and tetracycline (42.6 %) (table. 2). 
The rates of resistance in  Klebsiella spp to various 
antimicrobials are given below: gentamicin (54%), 
chloramphenicol (49%) cefuroxime (77.4%), cefotax-
ime (52%), ampicillin (98.7%), amoxicillin (71.4%), 
amoxiclav (52%), cefoperazone (32%) and tetracycline 
(62%). Klebsiella pneumoniae did not show resistance 
to amikacin and ciprofloxacin (Tab. II).
Tab. I. Number and percentage of isolated Species of Bacterial. 
Species of 
isolated Bacterial 
Number of 
isolated bacteria
Percentage of 
isolated bacteria
pseudomonas 
species 187 20.5%
Acinetobacter 
baumannii 74 8.13
Klebsiella spp 47 5.16%
escherichia coli 37 4.06%
pseudomonas 
aeruginosa  17 1.86%
Salmonella spp  10 1.09%
Tab. II. Frequency of antibiotics resistance.
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pseudomonas spp. 30.1% 10.8% 87.8% 96% 80.02% 69% 49.4% 35.2% 39.1% 22% 59% 32.1%
Acinetobacter species 11.5% 3.7% 84.2 % 83.2% 80.1% 75.4% 44.8% 45.2% 33.3% 19% 34.1% 32%
Salmonella spp.  21% 39% 46.4% 27.3% 15.4% - - - 32.5% 6.3% 9.1% 50%
escherichia coli  25% 18% 92% 90.9% 73.9% 54.5% 52.9% - 36.8% 31.6% 39% 39%
pseudomonas 
aeruginosa 
42.2% 30.8% 96.1% 92.9% 95.8% 81% 48.4% 34.2% 47.3% 22.4% 32% 42.6%
Klebsiella spp. 54% 0% 98.7% 52% 52% 77.4% 52% - 32% 0% 49% 62%
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Discussion
Bacterial antibiotics resistant is remaining as an al-
larming problem in the therapy of bloodstream infec-
tions  [16, 17]. Bacterial bloodstream infection mostly 
caused by strains that are resistant to a wide range of 
antimicrobial agents [18]. The current study investigated 
the antimicrobial resistance profile of 372 Gram-nega-
tive bacteria isolated from bloodstream infections. The 
data demonestrated the frequency of antimicrobial re-
sistance among bacterial pathogens isolated from blood-
stream infections. 
Gram-negative bacteria is the most cause of bloodstream 
infections in many conties [1, 2, 7, 18]. Also, this type of 
bacteria have been the most common contributing path-
ogens of bloodstream infections in the present study. 
This is considerable that, different etiological agents 
of bloodstream infections can be related to the varying 
demography of bloodstream infections in developing 
countries because of different geographical area. 
In some studies demonstrated that Acinetobacter spe-
cies,  Salmonella typhi  and  Escherichia coli  were the 
most common Gram-nagative bacteria that involve in 
that bloodstream infections  [19-21]. These results are 
approximately similar to our results in current study. 
Gram-negative bacteria is more resistance to antibiotics 
than Gram-positive. Acinetobacter  species demonstrat-
ed very high levels of resistance to beta-lactam antibiot-
ics in some reports [22, 23], that it is similar to the results 
of current study. Acinetobacter species showed the lower 
levels of resistance to aminoglycoside and low level 
resistance rates to quinolones. Similarly,  Escherichia 
coli demonstrated distinctly higher levels of resistance to 
beta-lactam antibiotics than other classes of antimicro-
bials. The organism demonstrated maximum resistance 
to ampicillin and minimum to amikacin [22, 23]. These 
results can support the finding of this study, because of 
our results of antibiotic susceptibility testing are similar 
to them. 
Conclusion
Extensive frequency of antimicrobial resistance levels 
were distinguished in our study, is similar to another 
studies [17, 18]. The high frequency of antibiotic resist-
ance rates in Children’s Medical Center might be be-
cause of indifferentiate and excess of use of treatment 
in our country because of their easy availability  [19]. 
The other cause might be frequency of ESBL produc-
tion among Gram-negative isolates from neonatal blood-
stream infection [20]. Also, other cause could be the al-
tering patterns of antibiotic utilize and varies in lifestyle. 
In the light of over findings there continues an increas-
ing requirement for new agents, though a recent study 
reported polymyxin are being restored to as potential 
choices for the therapy [21]. Proper antimicrobial treat-
ment for bloodstream infections is important in declin-
ing morbidity and mortality among patients with blood-
stream infections caused by bacteria. Therefore, accurate 
microbiological diagnosis and their antimicrobial resist-
ance profile can be very important for the rapid initiation 
of sufficient treatment for bloodstream infections [23].
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